Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > Sotagliflozin CAS 1018899-04-1

Sotagliflozin CAS 1018899-04-1

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 1018899-04-1

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15 days

Payment Terms: T/T, L/C, D/A, Western Union

Supply Ability: TON

Get Best Price
Highlight:
CAS NO::
1018899-04-1
Appearance::
A Crystalline Solid
Molecular Formula::
C21H25ClO5S
Molecular Weight::
424.93800
EINECS NO::
805-113-6
MDL NO::
MFCD22493506
CAS NO::
1018899-04-1
Appearance::
A Crystalline Solid
Molecular Formula::
C21H25ClO5S
Molecular Weight::
424.93800
EINECS NO::
805-113-6
MDL NO::
MFCD22493506
Sotagliflozin CAS 1018899-04-1

Product Description:

Product Name: Sotagliflozin CAS NO: 1018899-04-1

 

 

 

Synonyms:

LX4211;

LX4211/LX-4211;

 

 

 

Chemical & Physical Properties:

Appearance: A crystalline solid

Assay :≥98.0%

Density: 1.37±0.1 g/cm3 (Predicted)

Boiling point:607.9±55.0℃ (Predicted)

PKa: 12.87±0.70 (Predicted)

 

 

 

Safety Information:

Storage: -20℃

Shipping: Room Temperature in continental US; may vary elsewhere

Stability: ≥ 2 years

 

 

 

LX-4211 is an inhibitor of SGLT1/2 and is an anti-diabetic agent. LX-4211 is a novel oral diabetes drug developed by Sanofi and Lescon Pharmaceuticals. As a dual inhibitor of SGLT-1 and SGLT-2, the drug can reduce postprandial blood glucose, increase GLP-1 and promote urinary glucose excretion.

 

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.